hiv-infections

Documents about hiv-infections

• T-cell Responses to Concurrent HIV and Herpesvirus Infections#886023ClinicalTrials.gov
• Characterization of Acute and Recent HIV-1 Infections in Zurich.#909507ClinicalTrials.gov
• Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)#898422ClinicalTrials.gov
• Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid#840917ClinicalTrials.gov
• HIV Persistence and Viral Reservoirs#870583ClinicalTrials.gov
• Preparing for Adolescent HIV Vaccine Trials in South Africa:#125952ClinicalTrials.gov
• HORIZONS HIV Intervention#806891ClinicalTrials.gov
• iHIVARNA Clinical Trial in HIV Infected Individuals#398187ClinicalTrials.gov
• Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru#148559ClinicalTrials.gov
• Valganciclovir to Reduce T Cell Activation in HIV Infection#829455ClinicalTrials.gov
• Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load#850346ClinicalTrials.gov
• Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP#850075ClinicalTrials.gov
• CDC HIV Testing Guidelines: Unresolved Ethical Concerns#891045ClinicalTrials.gov
• Drug Interaction - Oral Contraceptive#881157ClinicalTrials.gov
• Non-Occupational HIV Post-Exposure Prophylaxis Update#393098Open Research
• In vitro diagnostic medical devices used for the quantitative detection of HIV-1 nucleic acid#267429WHO IRIS
• Subclinical Atherosclerosis in HIV-infected Patients#864742ClinicalTrials.gov
• Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV#172393ClinicalTrials.gov
• IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)#837870ClinicalTrials.gov
• CAR-T Cells for HIV Infection#827574ClinicalTrials.gov
• Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults#909819ClinicalTrials.gov
• Combination Vaccination Before HIV Treatment Interruption#811980ClinicalTrials.gov
• Candidate HIV Vaccine#162541ClinicalTrials.gov
• Dendritic Cell Vaccine in HIV-1 Infection#350007ClinicalTrials.gov
• Guidelines for the clinical management of HIV infection in adults#470963WHO IRIS
• Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults#633748ClinicalTrials.gov
• Pre-Exposure Prophylaxis Using TMC278LA#806664ClinicalTrials.gov
• HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia#831398ClinicalTrials.gov
• Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS#633771ClinicalTrials.gov
• Efficacy of Influenza Vaccine in HIV Infected Adults#234473ClinicalTrials.gov
• Qualitative Assessment of Implementing Routine Rapid HIV Testing#870501ClinicalTrials.gov
• An Affect Management Intervention for Juvenile Offenders#882646ClinicalTrials.gov
• Long-Term Data Collection From Participants in Adult AIDS Clinical Trials#893700ClinicalTrials.gov
• Immunogenicity of COVID-19 Vaccination in PLWH#201631ClinicalTrials.gov
• Hepatitis B Vaccination in HIV-infected Persons#283094ClinicalTrials.gov
• Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects#287377ClinicalTrials.gov
• The Safety and Immunogenicity of a Potential HIV Vaccine#417582ClinicalTrials.gov
• Bioequivalency Study of Zidovudine Under Fed Conditions#845750ClinicalTrials.gov
• HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting#839546ClinicalTrials.gov
• H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients#870518ClinicalTrials.gov
• A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials#158029ClinicalTrials.gov
• Family-Based HIV Prevention for Latinos#880277ClinicalTrials.gov
• Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection#268066ClinicalTrials.gov
• Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir#855603ClinicalTrials.gov
• Safety Study of Elvucitabine in HIV-1 Subjects#906135ClinicalTrials.gov
• Development of a New HIV Vaccine#859542ClinicalTrials.gov
• Cellulose Sulfate and HIV Transmission Among Women#898487ClinicalTrials.gov
• Diagnostics for HIV diagnosis#373051WHO IRIS
• HIV in Australian prisons : transmission, risk behaviours and prevention#376602UNSWorks Repository
• Structured Treatment Interruption (STI) in Acute/Primary HIV#391047ClinicalTrials.gov

Related topics